Barron’s has long favored dividend-paying stocks for those seeking income. But bonds now deserve a hard look because they are ...

China's biotech sector is rapidly advancing due to heavy R&D investment and a push for technological self-sufficiency. See ...

The Grignard Reagents market is witnessing steady demand across pharmaceuticals, agrochemicals, and chemical synthesis due to their versatility in or ...

SAN DIEGO, CA, UNITED STATES, July 2, 2025 /EINPresswire.com/ -- Stellar Market Research examines the growth rate of the Veterinary Pain Management Market during the forecasted period 2025-2032 The ...

Get the latest Merck & Co., Inc. (MRK) stock news and headlines to help you in your trading and investing decisions.

Review the current Merck & Co Inc (MRK:XNYS) dividend yield and history to decide if MRK is the best investment for you.

Review the current Merck & Co Inc (MRK:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if MRK is the best investment for you.

Merck now has one cardiovascular candidate left in phase 3: vericiguat, an oral soluble guanylate-cyclase (sGC) stimulator being studied as a new heart failure treatment.

Identifying stocks to buy and hold for decades rather than months or years can be difficult. The world and the economy are constantly changing, creating risks for long-term investors.